XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Beginning balance (in shares) at Jan. 31, 2023   293,822,850      
Beginning balance at Jan. 31, 2023 $ 6,206,607 $ 294 $ 4,104,880 $ (50,385) $ 2,151,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,044,922      
Issuance of common stock upon exercise of stock options 7,686 $ 1 7,685    
Issuance of common stock upon release of restricted stock units (in shares)   5,535,351      
Issuance of common stock upon release of restricted stock units 0 $ 6 (6)    
Issuance of common stock for employee stock purchase plan (in shares)   552,904      
Issuance of common stock for employee stock purchase plan 32,513 $ 1 32,512    
Stock-based compensation expense 544,450   544,450    
Other comprehensive (loss) income 13,678     13,678  
Net income 197,418       197,418
Ending balance (in shares) at Jul. 31, 2023   300,956,027      
Ending balance at Jul. 31, 2023 7,002,352 $ 302 4,689,521 (36,707) 2,349,236
Beginning balance (in shares) at Apr. 30, 2023   297,455,726      
Beginning balance at Apr. 30, 2023 6,524,107 $ 298 4,391,418 (34,871) 2,167,262
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   542,954      
Issuance of common stock upon exercise of stock options 3,417   3,417    
Issuance of common stock upon release of restricted stock units (in shares)   2,404,443      
Issuance of common stock upon release of restricted stock units 0 $ 3 (3)    
Issuance of common stock for employee stock purchase plan (in shares)   552,904      
Issuance of common stock for employee stock purchase plan 32,513 $ 1 32,512    
Stock-based compensation expense 262,177   262,177    
Other comprehensive (loss) income (1,836)     (1,836)  
Net income 181,974       181,974
Ending balance (in shares) at Jul. 31, 2023   300,956,027      
Ending balance at Jul. 31, 2023 7,002,352 $ 302 4,689,521 (36,707) 2,349,236
Beginning balance (in shares) at Jan. 31, 2024   307,558,353      
Beginning balance at Jan. 31, 2024 $ 8,019,406 $ 307 5,228,756 1,063 2,789,280
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 221,827 221,827      
Issuance of common stock upon exercise of stock options $ 1,855   1,855    
Issuance of common stock upon release of restricted stock units (in shares)   6,778,788      
Issuance of common stock upon release of restricted stock units 0 $ 7 (7)    
Issuance of common stock for employee stock purchase plan (in shares)   666,051      
Issuance of common stock for employee stock purchase plan 34,263 $ 1 34,262    
Repurchases of common stock (in shares)   (7,229,395)      
Repurchases of common stock (437,693) $ (7) (437,686)    
Stock-based compensation expense 470,965   470,965    
Other comprehensive (loss) income 1,128     1,128  
Net income 435,323       435,323
Ending balance (in shares) at Jul. 31, 2024   307,995,624      
Ending balance at Jul. 31, 2024 8,525,247 $ 308 5,298,145 2,191 3,224,603
Beginning balance (in shares) at Apr. 30, 2024   309,268,684      
Beginning balance at Apr. 30, 2024 8,298,824 $ 309 5,310,417 (17,490) 3,005,588
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   112,363      
Issuance of common stock upon exercise of stock options 839   839    
Issuance of common stock upon release of restricted stock units (in shares)   2,777,616      
Issuance of common stock upon release of restricted stock units 0 $ 3 (3)    
Issuance of common stock for employee stock purchase plan (in shares)   666,051      
Issuance of common stock for employee stock purchase plan 34,263 $ 1 34,262    
Repurchases of common stock (in shares)   (4,829,090)      
Repurchases of common stock (287,645) $ (5) (287,640)    
Stock-based compensation expense 240,270   240,270    
Other comprehensive (loss) income 19,681     19,681  
Net income 219,015       219,015
Ending balance (in shares) at Jul. 31, 2024   307,995,624      
Ending balance at Jul. 31, 2024 $ 8,525,247 $ 308 $ 5,298,145 $ 2,191 $ 3,224,603